Investors

Value proposition

Market Opportunity

  • The global market for NK cell therapy was valued at USD 347.8 million in 2022 and is projected to reach USD 1 million by 2028, with a compound annual growth rate of 17% during the forecast period.
  • The NK Media Market comprises two crucial components: research and clinical practice. The driving force behind these components is the enhanced potency and success rate of NK cell therapies. According to our estimates, the first wave of FDA-approved NK cell therapies is anticipated to emerge between 2025 and 2026.
Market-Opportunity

Two Phase Media Format

Enable-NK™ Duo is a set of 2 cell culture media consisting of Enable-NK™ Grow and Enable-NK™ Activate formulated specifically for human natural killer (NK) cells, and is xeno-free.

Enable-NK™ Duo consists of two different formulations, each with a specific purpose.

investment-phase

Our Edge

Through crafted formulations and cutting-edge technologies, we have harnessed the forces of nature to empower cells to proliferate at accelerated rates, all while maintaining optimal viability. This synergy of growth and health is a hallmark of our dedication to pushing the boundaries of what is achievable in cellular applications.

Increased proliferation

Increased proliferation

Higher Viability

Higher Viability

Low Medium Requirements

Our product’s edge in the field that sidesteps the conventional requirements of excessive cytokine usage. Our medium, uniquely formulated to minimise the need for supplements, provides a remarkable advantage over competitors who rely heavily on cytokine supplementation. By reducing the dependency on supplements like cytokines, we effectively eliminate some of the hidden costs associated with NK cellular culturing.

COMPARISON CHART

Media Requirement IL-2 IL-12 IL-15 IL-18 IL-21
Enable-NK™ Duo 100 U/ml - - - -
Competitor 1 100 U/ml - 140 U/ml - -
Competitor 2 500 U/ml - - - -
Competitor 3 27 ng/ml 10 U/ml - 10 U/ml 10 U/ml

Sectors and Industries

With a focus on breakthrough advancements in biotechnology, we are positioned at the intersection of healthcare, life sciences, and cellular research. This convergence empowers us to redefine the possibilities of disease treatment, immune response enhancement, and precision medicine. Explore how our NK media is influencing and transforming these vital sectors, setting a new standard for excellence and pioneering a healthier future for humanity.

Sectors and Industries